期刊文献+

本草学毒性理念的源流探考与论述范式的诠解 被引量:3

Origin and development of concept of toxicology in herbalism
原文传递
导出
摘要 本草学是在传统医学理论指导下对传统"药"学的统称。中药的毒性理论蕴含于本草学药性理论之中,其论述范式则指撰写本草学著作所应用的指导原则。毒性理论的论述范式是经《神农本草经》《新修本草》《证类本草》的传承逐渐形成的,其形成在汉代"生生不息"观念的凝结中又涵摄了药性、毒副作用、药材基原、药材制备及配伍等复杂面向。经探考发现传统的"有故无殒"药性作用部分应回归四气及气味厚薄的记述;不当的药材基原部分应统属于药材来源的管控;特殊体质的不良服药反应不应归于毒性的记述,因剂量不宜或服用方法不当所产生的不良反应应回归到国家相关部门建议的项目之下;毒性分级分类的标准须有现代毒理的研究为基础同时严格限制使用剂量与适用范围。这将有助于重新建构既兼顾中药用药安全又能最大限度发挥中药特色的现代本草学。 Materia medica is the traditional medicine theory under the guidance of the traditional "medicine" science cotlectively. The toxicity theory of Chinese materia medica (CMM) is contained in the herbal theory of herbs, and the paradigm of hermeneutics is the guideline applied in writing the herbal literature. The form of the theory of toxicity is the result of the formation of mainstream of series ofmateria medica such as Shennong's Classic ofMateria Medica. Its formation is the condensation under the conception of Never end in the Han Dynasty, which contains the medicinal properties, toxic and side effects, compatibility, and other complex oriented. The exploration of the traditional "do not die" medicinal part should return to the four gas and odor thickness of the account; the original part of improper medicine should belong to the control of the source of medicine; Special physical adverse drug reactions should not be attributed to toxicity, due to dose or improper use of the adverse reactions should be returned to the relevant state departments under the proposed project; Toxic classification criteria must be based on modem toxicology research while strictly limiting the dose and scope of application. This will help to re-build CMM safety and maximize the characteristics of CMM to the modem herbal medicine.
作者 王进 王旭东 吴承艳 朱博冉 WANG Jin WANG Xu-dong WU Cheng-yan ZHU Bo-ran(Institute of Chinese Classics in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China Chinese Medicine Culture Study Center, Nanjing University of Chinese Medicine, Nanjing 210023, China)
出处 《中草药》 CAS CSCD 北大核心 2017年第1期197-202,共6页 Chinese Traditional and Herbal Drugs
基金 国家社会科学基金重大项目(12&ZD114) 国家自然科学基金项目面上项目(81574099) 江苏高校优势学科建设工程资助项目(PAPD) 江苏省教育厅哲学社会科学重点基地"中医文化研究中心"基金项目 江苏省社会科学基金重点项目(14LSA001) 南京中医药大学开放课题(WW2013-05)
关键词 本草学 传统药 毒性 用药安全 herbalism traditional medicines poison toxicity medication safety
  • 相关文献

参考文献4

二级参考文献30

  • 1周仲瑛.“伏毒”新识[J].世界中医药,2007,2(2):73-75. 被引量:137
  • 2王永炎.关于提高脑血管疾病疗效难点的思考[J].中国中西医结合杂志,1997,17(4):195-196. 被引量:597
  • 3SIEGEL R,JIEMIN MA,ZHAO HUI ZOU,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64 (1):9-29.
  • 4SIEGEL R,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.
  • 5MARCO A V,NORA H,MARISOL D F,et al.Breast Cancer Stem Cells[J].Biochem Cell Biol,2012,44(4):573-577.
  • 6PONTI D,COSTA A,ZAFFARONI N,et al.Isolation and in vitro propagation of tumorigenic breast cancer cells with stern/progenitor cell properties[J].Cancer Res,2005,65(13):5506-5511.
  • 7MANI SA,GUO W,LIAO MJ,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells[J].Cell,2008,133(4):704-715.
  • 8CHAD J C,DON L G,JONATHAN M K.The role of epithelial-mesenchymal transition programming in invasion and metastasis:a clinical perspective[J].Cancer Management and Research,2013,5(7):187-195.
  • 9AKALAY I,JANJI B,HASMIM M,et al.Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated Iysis[J].Cancer Res,2013,73(8):2418-2427.
  • 10GAL A,SJOBLOM T,FEDOROVA L,et al.Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells,leading to EMT and inhibition of growth arrest and apoptosis[J].Oncogene,2008,27(9):1218-1230.

共引文献80

同被引文献58

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部